Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics.

PLoS pathogens - 1 Aug 2013

Smith Everett Clinton, Blanc Hervé, Surdel Matthew C, Vignuzzi Marco, Denison Mark R

Abstract excerpt

No therapeutics or vaccines currently exist for human coronaviruses (HCoVs). The Severe Acute Respiratory Syndrome-associated coronavirus (SARS-CoV) epidemic in 2002-2003, and the recent emergence of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in April 2012, emphasize the high probability of future zoonotic HCoV emergence causing severe and lethal human disease. Additionally, the resistance of...

Topics

Join the communities discussing this publication.

Astrocytoma
Brain Neoplasms
Coronavirus
Coronavirus Infections
Exoribonucleases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Real-Time Polymerase Chain Reaction

Source

Open in PubMed Open full text

Identifiers

PMID: 23966862
DOI: 10.1371/journal.ppat.1003565
PMCID: PMC3744431

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics.PMID 23966862Read ↗

The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2.Semantic proximity Read ↗

Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness, and pathogenesis of SARS-CoV-2.Semantic proximity Read ↗

Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoNSemantic proximity Read ↗

The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic targetSemantic proximity Read ↗

The enzymatic activity of the nsp14 exoribonuclease is critical for replication of Middle East respiratory syndrome-coronavirusSemantic proximity Read ↗

Recovery of proofreading-impaired SARS-CoV-2 reveals a mutator phenotype and an ExoN activity threshold for viabilitySemantic proximity Read ↗

Recovery of proofreading-impaired SARS-CoV-2 reveals a mutator phenotype and an ExoN activity threshold for viability.Semantic proximity Read ↗

Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness and pathogenesis of SARS-CoV-2Semantic proximity Read ↗

Proofreading-Deficient Coronaviruses Adapt for Increased Fitness over Long-Term Passage without Reversion of Exoribonuclease-Inactivating Mutations.Semantic proximity Read ↗

Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing.Semantic proximity Read ↗

Coronaviruses as DNA Wannabes: A New Model for the Regulation of RNA Virus Replication FidelitySemantic proximity Read ↗

The coronavirus proofreading exoribonuclease mediates extensive viral recombinationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.